29
Feb
2008
Michael Bristow, M.D., Ph.D. Wins 2008 PhRMA Award
Posted in CO Pub Rel: Gilead, CO Pub Rel: GSK, CO Public: Myogen, People
Congratulations to Michael Bristow, M.D., Ph.D., the S. Gilbert Blount Professor of Medicine at University of Colorado, Head of Cardiology, Co-director of the University of Colorado Cardiovascular Institute, co-founder of Myogen (acquired by Gilead (NASDAQ: GILD), founder of ARCA Discovery and now add to that list winner of the Pharmaceutical Research and Manufacturers of America [...]
28
Feb
2008
IMHO I remain incredibly optimistic about Replidyne’s (NASDAQ: RDYN), a leader in next-generation anti-infective products, direction (note: this in no why should be interpreted as investment advice). After being dealt a bum deal by the FDA re: a change in protocol for antibiotic trials, management at Replidyne has retrenched. With $90.3M in cash on the [...]
27
Feb
2008
Cultivating a career in the business of science at times appears to be more art then science. Then there are impactful opportunities such as the Colorado Bio Fellows program that come along, which will hopefully continue to grow and function to shine a light down the path of transition from the ‘bench to the boardroom’ [...]
27
Feb
2008
All along the Front Range I can hear the sound of patents and articles-of-incorporation being filed, and new life science entities opening their doors. Larimer County is a concentrated region certainly a-buzz with such entrepreneurial activity. If you have not done so yet be certain to take a look at the Larimer Bioscience Cluster web [...]
26
Feb
2008
CLSDF has highlighted the history and relationship of Archemix to CO in previous posts; read about it (here). It has been a very busy 2008 thus far for the Cambridge-based aptamer therapeutics company who has now (I believe it is technically a – sub – based upon University Colorado orgins…?) licensed out the right to [...]
25
Feb
2008
HB08-1001: Takes A Huge ($2M) Leap!
Posted in My Rants
Our community is feverishly watching the progress of House Bill 1001. CLSDF began a series (here). A by-product of this process has been really learning the nuts and bolts of the legislative process and the lengthy and twisting journey a bill must endure to become law. HB1001’s most recent stop following its 9 January Introduction [...]
25
Feb
2008
Rocky Mountain Biosystems, Inc. (Wheat Ridge) announced receipt of a $600,000 Phase II SBIR grant from the NIH’s National Institute of Allergy and Infectious Diseases enabling continued work on their Self-Administered Vaccine Electromechanical (SAVE) technology. SAVE is a very smart, needle free, wristwatch-sized transdermal vaccine delivery technology system. This device-based platform rather uniquely enables one [...]
25
Feb
2008
At FBBp we are afforded the opportunity to work with people of extraordinary caliber. One such individual is Sandeep Wadhwa, MD, MBA who has accepted a position within the Colorado Department of Health Care Policy and Financing where he will be functioning as the State’s Medicaid Program Director. In his new role Dr. Wadhwa will [...]
22
Feb
2008
Kythera Lands Joe Turner on Board
Posted in CO Pri Rel: Kythera Biopharma, CO Pub Rel: Merck, People
Joe Turner, former Chief Financial Officer at Myogen (now Gilead (NASDAQ: GILD)), has joined the privately held Los Angeles-based Kythera Biopharmaceuticals Board of Directors. Not only is Joe an incredibly talented executive and individual but most selfishly he too has had a profound impact upon my personal life and professional development, and for that I [...]
21
Feb
2008
Attend the AECD Investors Forum
Posted in My Rants
Come join us at the Adam’s County Economic Development Investors Forum next Thursday 28 February 11:00am to 1:00pm for lunch and to listen to Jim Chrisman of Forest City Fitzsimons talk about the master development plan for the Colorado Science + Technology Park @ Fitzsimons. It promises to be a fascinating 2 hours. If you [...]
21
Feb
2008
There is nothing quite like waking up and laughing. This morning a quick 5:30am scan of my RSS reader landed me on my friend and founder of StartUp Weekend Andrew Hyde’s blog where I read about his latest endeavor, Venture Capital Wear: Clothing for the Top 2/20% of the Population, the tag line had me [...]
20
Feb
2008
PhosphoSolutions (Aurora) is focused upon the delivery of high quality phospho-specific antibodies. The detection and quantitation of changes in the state of phosphorylation of specific proteins is of great utility in the quest to establish the function of a given protein and the consequences of its reversible phosphorylation. The use of phosphorylation state-specific antibodies takes [...]
19
Feb
2008
Be certain to take a look at the most recent communication from CU Tech Transfer Office; the 2006-2007 Biomedical Venture and Commercialization Summary, only 4-pages long yet chock full ‘o rather impressive data and correlated information. It is just a fantastic accumulating track record of successful University biomedical spin-out start-up fund raising and commercialization efforts [...]
Life Science Deal Flow PARTNERS
-
